GERMAINE EURICH: Open Payments
NPI 1154316313 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 44 payments from 14 companies in 2025. Trend: 2023 $1,469 · 2024 $1,373 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $194 |
| Novartis Pharmaceuticals Corporation | 9 | $183 |
| Novo Nordisk Inc | 8 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $111 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Radius Health, Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| CVRx, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: VRAYLAR, LEQVIO, JARDIANCE, AIRSUPRA, Ozempic, Tymlos, GEMTESA, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
